NeuroTherapia Inc., a clinical-stage company based in Cleveland that is developing therapies for neurodegenerative diseases, announced it has closed an $8.8 million Series A financing round.
The round was led by Brain Trust Accelerator Fund II and included investments from the Cleveland Clinic Foundation, Dolby Family Ventures and Alzheimer’s Drug Discovery Foundation, NeuroTherapia said in a news release issued Tuesday, Sept. 22.
Click here to read the complete story.
Story excerpt provided by Crain’s Cleveland Business.
Written by Scott Suttell.
Originally published September 22, 2020.